Arcturus Therapeutics Holdings Inc. (ARCT) financial statements (2020 and earlier)

Company profile

Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO, CA 92121
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37
Cash and cash equivalents37
Receivables4
Other undisclosed current assets1
Total current assets:42
Noncurrent Assets
Property, plant and equipment2
Long-term investments and receivables0
Long-term investments0
Restricted cash and investments0
Total noncurrent assets:2
TOTAL ASSETS:44
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6
Accounts payable2
Accrued liabilities4
Other undisclosed current liabilities6
Total current liabilities:13
Noncurrent Liabilities
Long-term debt and lease obligation10
Long-term debt, excluding current maturities10
Liabilities, other than long-term debt1
Deferred rent credit1
Other undisclosed noncurrent liabilities8
Total noncurrent liabilities:18
Total liabilities:31
Stockholders' equity
Stockholders' equity attributable to parent14
Common stock0
Additional paid in capital58
Accumulated deficit(45)
Total stockholders' equity:14
TOTAL LIABILITIES AND EQUITY:44

Income statement (P&L) ($ in millions)

12/31/2018
Gross profit:16
Operating expenses(38)
Operating loss:(22)
Nonoperating income
(Other Nonoperating income)
0
Interest and debt expense(0)
Loss from continuing operations before equity method investments, income taxes:(22)
Loss from equity method investments(0)
Other undisclosed income from continuing operations before income taxes0
Net loss available to common stockholders, diluted:(22)

Comprehensive Income ($ in millions)

12/31/2018
Net loss:(22)
Comprehensive loss:(22)
Other undisclosed comprehensive income, net of tax, attributable to parent0
Comprehensive loss, net of tax, attributable to parent:(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: